Randomized, Doble-blind, Parallel-Group, Placebo-Controlled Study to Asses the Efficacy, Safety, Tolerability and Pharmacokinetics of BIIB033 in subjets with First Episode of Acute Optic Neuritis
PPD, Parmaceutical Product Development S.L.
Pathology and candidate patients
Dr. Luís Martí Bonmatí
Hospital Quirónsalud Valencia.
December 30, 2012
Hospital La Fe de Valencia
If you are interested in this clinical trial because you believe that you or a family member of yours can benefit from this new treatment.
You can request a consultation with the image diagnosis team by sending an email to the address: firstname.lastname@example.org